Patents by Inventor Elazer R. Edelman

Elazer R. Edelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120263672
    Abstract: Biocompatible adhesive materials, such as for use with biological tissues and/or medical implants, are provided, as well as methods and kits for making and using the biocompatible adhesive materials. The biocompatible adhesive materials include a dendrimer component and a polymer component, and may be tailored for specific tissue types and conditions.
    Type: Application
    Filed: April 13, 2012
    Publication date: October 18, 2012
    Applicant: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: Natalie Artzi, Elazer R. Edelman, Núria Oliva Jorge, Maria Carcolé Solanes
  • Patent number: 8252339
    Abstract: A method for medical treatment was developed in which microspheres with novel properties are administered in a mammal. The microspheres are made using a novel process that results in microspheres with new combined properties of high density, low fracture, high swell capacity, rapid swell, and deformability following swell. These microspheres may be administered for void filling, tissue bulking, non-vasculature occlusion, body fluid absorption, and delivery of medications.
    Type: Grant
    Filed: April 5, 2007
    Date of Patent: August 28, 2012
    Assignees: E I du Pont de Nemours and Company
    Inventors: Garret D. Figuly, Surbhi Mahajan, Rinaldo S. Schiffino, Sujata K. Bhatia, Elazer R. Edelman, Tarek Michael Shazly, Michael Jordan Feldstein
  • Patent number: 8206435
    Abstract: An expandable medical device has elongated struts joined together to form a substantially cylindrical device which is expandable from a cylinder having a first diameter to a cylinder having a second diameter. At least one of the struts includes at least one opening extending at least partially through a thickness of the strut. A beneficial agent is loaded into the opening within the strut in layers to achieve desired temporal release kinetics of the agent. Alternatively, the beneficial agent is loaded in a shape which is configured to achieve the desired agent delivery profile. A wide variety of delivery profiles can be achieved including zero order, pulsatile, increasing, decrease, sinusoidal, and other delivery profiles.
    Type: Grant
    Filed: February 23, 2009
    Date of Patent: June 26, 2012
    Inventors: John F. Shanley, Neal L. Eigler, Kinam Park, Elazer R. Edelman
  • Patent number: 8202313
    Abstract: An expandable medical device having a plurality of elongated struts, the plurality of elongated struts being joined together by ductile hinges to form a substantially cylindrical device which is expandable from a cylinder having a first diameter to a cylinder having a second diameter. The plurality of struts and ductile hinges are arranged to improve the spatial distribution of the struts which is particularly important when delivering beneficial agents with the struts. The improved strut arrangement expands to a substantially parallelogram shape for improved beneficial agent distribution to the surrounding tissue. A beneficial agent may be loaded into openings within the struts or coated onto the struts for delivery to the tissue.
    Type: Grant
    Filed: May 19, 2004
    Date of Patent: June 19, 2012
    Inventors: John F. Shanley, Neal L. Eigler, Elazer R. Edelman
  • Patent number: 8187321
    Abstract: An expandable medical device has a plurality of elongated struts joined together to form a substantially cylindrical device which is expandable from a cylinder having a first diameter to a cylinder having a second diameter. At least one of the plurality of struts includes at least one opening extending at least partially through a thickness of said strut. A beneficial agent is loaded into the opening within the strut in layers to achieve desired temporal release kinetics of the agent. Alternatively, the beneficial agent is loaded in a shape which is configured to achieve the desired agent delivery profile. A wide variety of delivery profiles can be achieved including zero order, pulsatile, increasing, decrease, sinusoidal, and other delivery profiles.
    Type: Grant
    Filed: September 7, 2005
    Date of Patent: May 29, 2012
    Assignee: Innovational Holdings, LLC
    Inventors: John F. Shanley, Neal L. Eigler, Kinam Park, Elazer R. Edelman
  • Publication number: 20120027858
    Abstract: The invention relates to composition and a method of using the composition for modulating proliferation, invasiveness, the expression of a biomarker of an abnormal cell, of reducing the risk of a patient cell becoming abnormal, or of modulating proliferation of a carcinoma-associated fibroblast or of a tumor-associated macrophage. The invention also relates to a method of culturing the composition to produce molecules that modulate abnormal cell proliferation, invasiveness, or metastasis. The composition comprises a biocompatible matrix and cells engrafted thereon.
    Type: Application
    Filed: February 4, 2010
    Publication date: February 2, 2012
    Applicant: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: Joseph W. Franses, Elazer R. Edelman, Angelo Manuel De Almeida Cardoso, Helen Marie Nugent
  • Publication number: 20120010690
    Abstract: A method and apparatus to create a more favorable flow regime in a lumen. An artificial shape in the lumen is created to at least one of eliminate flow disturbances and enchance aspects of fluid flow through a treatment site.
    Type: Application
    Filed: September 20, 2011
    Publication date: January 12, 2012
    Applicant: MEDINOL LTD.
    Inventors: Yoram Richter, Elazer R. Edelman
  • Patent number: 8062673
    Abstract: A method for embolization treatment was developed in which microspheres with novel properties are administered in a mammal. The microspheres are made using a novel process that results in microspheres with new combined properties of high density, low fracture, high swell capacity, rapid swell, and deformability following swell. These microspheres form occlusions with high durability, withstanding over 100 mm Hg (13.3 kPa) of pressure.
    Type: Grant
    Filed: April 5, 2007
    Date of Patent: November 22, 2011
    Assignee: E I Du Pont de Nemours and Company
    Inventors: Garret D. Figuly, Surbhi Mahajan, Rinaldo S. Schiffino, Michael Jordan Feldstein, Tarek Michael Shazly, Elazer R. Edelman
  • Publication number: 20110112630
    Abstract: The present embodiments relate to systems and methods for treating lumenal valves. Particularly, and in accordance with one aspect, the present disclosure is directed to methods and systems for partial or complete replacement of lumenal valves. An exemplary catheter in accordance with the disclosure includes an elongate body having a proximal end and a distal end, and a retractable sheath mounted on the elongate body proximate the distal end. The sheath and elongate body cooperating to define a first annularly-shaped compartment between the body and sheath. The catheter further includes a valve prosthesis mounted in the compartment, the prosthesis having proximal and distal ends connected to a means for deploying the valve prosthesis from the catheter.
    Type: Application
    Filed: October 6, 2010
    Publication date: May 12, 2011
    Inventors: Adam Groothuis, Adrian Ebner, Peter Markham, Elazer R. Edelman
  • Publication number: 20110085712
    Abstract: A method for imaging the erosion of a biomaterial is disclosed. More specifically, the present invention provides a method for imaging a labeled biomaterial so that the erosion of the biomaterial is measured in vivo over a period of time. A biomaterial such as, for example, a hydrogel including polyethylene glycol (PEG) is labeled with a fluorescent or bioluminescent marker. The labeled biomaterial is then employed in the construction of an implanted medical device such as, for example, an endovascular stent. Furthermore, the labeled biomaterial may be utilized to form a drug delivery system that releases a controlled amount of a drug into a local region within a patient. The erosion of the biomaterial is monitored through a noninvasive imaging method.
    Type: Application
    Filed: October 13, 2009
    Publication date: April 14, 2011
    Inventors: Natalie Artzi, Elazer R. Edelman
  • Publication number: 20110004293
    Abstract: A drug delivering medical system intended for placement into a blood vessel is provided. The drug delivering medical system includes a stent device having a plurality of interconnected distinct strut elements comprising distinct strut element surfaces. At least some of the distinct strut surfaces are neither in contact with the lumen wall nor in contact with wall-contacting flow recirculation zones. The stent device releases at least one biologically active compound intended for distal delivery and provides sufficient surface area for delivering the required drug dose to a distal tissue.
    Type: Application
    Filed: July 12, 2010
    Publication date: January 6, 2011
    Inventors: Kumaran Kolandaivelu, Abraham Tzafriri, Vijaya B. Kolachalama, Elazer R. Edelman
  • Publication number: 20100318173
    Abstract: A stent alignment system includes an implantable stent and catheter that allows the ability to precisely control translational and rotational position in a vessel of the implantable stent and catheter.
    Type: Application
    Filed: June 21, 2010
    Publication date: December 16, 2010
    Inventors: Kumaran Kolandaivelu, Rajesh V. Swaminathan, William J. Gibson, Elazer R. Edelman
  • Patent number: 7842083
    Abstract: An expandable medical device having a plurality of elongated struts, the plurality of elongated struts being joined together by ductile hinges to form a substantially cylindrical device which is expandable from a cylinder having a first diameter to a cylinder having a second diameter. The plurality of struts and ductile hinges are arranged to improve the spatial distribution of the struts which is particularly important when delivering beneficial agents with the struts. The improved strut arrangement expands to a substantially parallelogram shape for improved beneficial agent distribution to the surrounding tissue. A beneficial agent may be loaded into openings within the struts or coated onto the struts for delivery to the tissue.
    Type: Grant
    Filed: February 27, 2006
    Date of Patent: November 30, 2010
    Assignee: Innovational Holdings, LLC.
    Inventors: John F. Shanley, Neal L. Eigler, Elazer R. Edelman
  • Publication number: 20100239671
    Abstract: Endothelial implants restore vascular homeostasis after injury without reconstituting vascular architecture. Endothelial cells line the vascular epithelium and underlying vasa vasorum precluding distinction between cellular controls. Unlike blood vessels, the airway epithelium is highly differentiated and distinct from endothelial cells that line the bronchial vasa allowing investigation of the differential control tissue engineered cells may provide in airways and blood vessels. Through airway injury and cell culture models, tissue engineered implants of the bronchial epithelium and endothelium were found to promote synergistic repair of the airway through biochemical regulation of the airway microenvironment. While epithelial cells modulate local tissue composition and reaction, endothelial cells preserve the epithelium; together their relative impact was enhanced suggesting both cell types act synergistically for airway repair.
    Type: Application
    Filed: May 6, 2008
    Publication date: September 23, 2010
    Inventors: Elazer R. Edelman, Brett Zani
  • Publication number: 20100228280
    Abstract: The invention provides a variety of catheters and methods for using such catheters. An exemplary catheter includes an elongate body having a proximal end a distal end. The elongate body defines a longitudinal axis of the catheter. The exemplary catheter further includes at least one inflatable member disposed on the elongate body proximate the distal end of the elongate body. The interior of the inflatable member is in fluid communication with an inflation lumen in the elongate body. The exemplary catheter also includes a first filter adapted and configured to capture emboli in a patient's bloodstream as the bloodstream passes through the first filter along a first direction. The exemplary catheter further includes a second filter adapted and configured to capture emboli in a patient's bloodstream as the bloodstream passes through the second filter along a second direction, wherein the second direction is generally opposite to the first direction.
    Type: Application
    Filed: March 9, 2009
    Publication date: September 9, 2010
    Inventors: Adam Groothuis, Edward I. McNamara, Peter Markham, Elazer R. Edelman
  • Publication number: 20100114302
    Abstract: Endovascular devices are provided. The endovascular devices include a conformable scaffold with one or more outpocketings. The outpocketing in the endovascular device creates a corresponding outpocketing of a vessel wall, thereby altering local fluid dynamics.
    Type: Application
    Filed: July 24, 2007
    Publication date: May 6, 2010
    Inventors: Abraham Tzafriri, Kumaran Kolandaivelu, Elazer R. Edelman
  • Publication number: 20100092532
    Abstract: Disclosed herein are materials and methods suitable for treating sites of pathological angiogenesis and abnormal neovascularization. Sites of pathological angiogenesis or abnormal neovascularization can be treated by contacting a surface at or adjacent or in the vicinity of an area of pathological angiogenesis or abnormal neovascularization with an implantable material. The implantable material comprises a biocompatible matrix and cells and is in an amount effective to treat the affected site. The composition can be a flexible planar material or a flowable composition. Diseases susceptible to treatment with the present invention include, for example, macular degeneration, rheumatoid arthritis, psoriasis, psoriatic arthritis, systemic inflammatory diseases, and treatment of tumors by surgical resection, radiation therapy or chemotherapy.
    Type: Application
    Filed: November 7, 2007
    Publication date: April 15, 2010
    Inventors: Helen Marie Nugent, Elazer R. Edelman, Robert M. Tjin Tham Sjin, Yin Shan Ng
  • Publication number: 20100042200
    Abstract: A method and an apparatus to create a more favorable flow regime in a lumen. An artificial shape in the lumen is created to at least one of eliminate flow disturbances and enhance aspects of fluid flow through a treatment site.
    Type: Application
    Filed: August 14, 2009
    Publication date: February 18, 2010
    Applicant: MEDINOL, LTD.
    Inventors: Yoram RICHTER, Elazer R. EDELMAN
  • Publication number: 20090220588
    Abstract: The compositions and methods of the present invention relate to the co-delivery of a molecule and a polypeptide to cells to improve the therapeutic efficacy of the molecules. In one embodiment of the invention, the invention may improve delivery of growth factors by co-delivering these growth factors with their receptors and co-receptors, such as syndecans. Co-delivery of growth factors with syndecans, for example, may protect growth factors from proteolysis, enhance their activity, and target the growth factors to the cell surface to facilitate growth factor signaling. This novel approach to growth factor therapy could be extended to other systems and growth factors enabling the enhancement of multiple signaling pathways to achieve a desired therapeutic outcome.
    Type: Application
    Filed: February 20, 2009
    Publication date: September 3, 2009
    Applicant: Massachusetts Institute of Technology
    Inventors: Elazer R. Edelman, Aaron B. Baker
  • Publication number: 20090163995
    Abstract: An expandable medical device has a plurality of elongated struts joined together to form a substantially cylindrical device which is expandable from a cylinder having a first diameter to a cylinder having a second diameter. At least one of the plurality of struts includes at least one opening extending at least partially through a thickness of said strut. A beneficial agent is loaded into the opening within the strut in layers to achieve desired temporal release kinetics of the agent. Alternatively, the beneficial agent is loaded in a shape which is configured to achieve the desired agent delivery profile. A wide variety of delivery profiles can be achieved including zero order, pulsatile, increasing, decrease, sinusoidal, and other delivery profiles.
    Type: Application
    Filed: February 23, 2009
    Publication date: June 25, 2009
    Inventors: John F. Shanley, Neal L. Eigler, Kinam Park, Elazer R. Edelman